HK Stock MarketDetailed Quotes

02348 DAWNRAYS PHARMA

Watchlist
  • 1.200
  • +0.030+2.56%
Noon Break Apr 29 11:11 CST
1.80BMarket Cap5.00P/E (TTM)

DAWNRAYS PHARMA Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:CNY
2023/FY
Stock NameRevenueRatio
Proprietary medicine1.02B88.76%
Intermediates and APIs129.42M11.24%
Product Currency:CNY
2019/FY
Stock NameRevenueRatio
Proprietary medicine713.76M75.13%
Intermediates and APIs236.25M24.87%
Region Currency:CNY
2023/FY
Stock NameRevenueRatio
Chinese mainland1.13B98.55%
Other countries16.73M1.45%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg